[6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+))

C181H146BN19O2Pt5SSi — CID 159911586

About [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+))

[6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+)) (PubChem CID 159911586) has the molecular formula C181H146BN19O2Pt5SSi and a molecular weight of 3665.64 g/mol. Its IUPAC name is [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+)).

Molecular Properties

• Compound Name: [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+))
• PubChem CID: 159911586
• Molecular Formula: C181H146BN19O2Pt5SSi
• Molecular Weight: 3665.64 g/mol
• Exact Mass: 3662.97
• IUPAC Name: [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+))
• SMILES: CCN(c1ccc2c3ccccc3n(-c3[c-]cccc3)c2n1)c1nc(-c2[c-]cccc2)cn1-c1c(C)cccc1C.CCc1cccc(CC)c1-n1cc(-c2[c-]cccc2)nc1Sc1cccc([Si](c2[c-]cccc2)(c2ccccc2)c2ccccc2)n1.Cc1cccc(C)c1-n1cc(-c2[c-]cccc2)nc1B(c1ccccc1)c1cccc(N(c2[c-]cccc2)c2ccccc2)n1.Cc1cccc(C)c1-n1cc(-c2[c-]cccc2)nc1Cc1cn(C)c(Oc2[c-]cccc2)n1.Cc1cccc(C)c1-n1cc(-c2[c-]cccc2)nc1Oc1cccc(C(c2[c-]cccc2)c2ccccc2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2]
• InChI: InChI=1S/C42H35N3SSi.C40H31BN4.C36H29N5.C35H27N3O.C28H24N4O.5Pt/c1-3-32-21-17-22-33(4-2)41(32)45-31-38(34-19-9-5-10-20-34)43-42(45)46-39-29-18-30-40(44-39)47(35-23-11-6-12-24-35,36-25-13-7-14-26-36)37-27-15-8-16-28-37;1-30-17-15-18-31(2)39(30)44-29-36(32-19-7-3-8-20-32)42-40(44)41(33-21-9-4-10-22-33)37-27-16-28-38(43-37)45(34-23-11-5-12-24-34)35-25-13-6-14-26-35;1-4-39(36-37-31(27-16-7-5-8-17-27)24-40(36)34-25(2)14-13-15-26(34)3)33-23-22-30-29-20-11-12-21-32(29)41(35(30)38-33)28-18-9-6-10-19-28;1-25-14-12-15-26(2)34(25)38-24-31(27-16-6-3-7-17-27)37-35(38)39-32-23-13-22-30(36-32)33(28-18-8-4-9-19-28)29-20-10-5-11-21-29;1-20-11-10-12-21(2)27(20)32-19-25(22-13-6-4-7-14-22)30-26(32)17-23-18-31(3)28(29-23)33-24-15-8-5-9-16-24;;;;;/h5-19,21-27,29-31H,3-4H2,1-2H3;3-19,21-25,27-29H,1-2H3;5-16,18,20-24H,4H2,1-3H3;3-16,18-20,22-24,33H,1-2H3;4-13,15,18-19H,17H2,1-3H3;;;;;/q5*-2;5*+2
• InChIKey: VXUZYIGMMOFZHU-UHFFFAOYSA-N
• XLogP: 36.72
• TPSA: 188.35 Ų
• H-Bond Acceptors: 22
• Rotatable Bonds: 37
• Heavy Atoms: 210
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3665.64
LogP ≤ 5	36.72
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	22

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+))?

The IUPAC name of [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+)) (CID 159911586) is [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+)).

What is the SMILES notation for [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+))?

The canonical SMILES for [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+)) is CCN(c1ccc2c3ccccc3n(-c3[c-]cccc3)c2n1)c1nc(-c2[c-]cccc2)cn1-c1c(C)cccc1C.CCc1cccc(CC)c1-n1cc(-c2[c-]cccc2)nc1Sc1cccc([Si](c2[c-]cccc2)(c2ccccc2)c2ccccc2)n1.Cc1cccc(C)c1-n1cc(-c2[c-]cccc2)nc1B(c1ccccc1)c1cccc(N(c2[c-]cccc2)c2ccccc2)n1.Cc1cccc(C)c1-n1cc(-c2[c-]cccc2)nc1Cc1cn(C)c(Oc2[c-]cccc2)n1.Cc1cccc(C)c1-n1cc(-c2[c-]cccc2)nc1Oc1cccc(C(c2[c-]cccc2)c2ccccc2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].

What is the InChIKey of [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+))?

The InChIKey is VXUZYIGMMOFZHU-UHFFFAOYSA-N. The full InChI is InChI=1S/C42H35N3SSi.C40H31BN4.C36H29N5.C35H27N3O.C28H24N4O.5Pt/c1-3-32-21-17-22-33(4-2)41(32)45-31-38(34-19-9-5-10-20-34)43-42(45)46-39-29-18-30-40(44-39)47(35-23-11-6-12-24-35,36-25-13-7-14-26-36)37-27-15-8-16-28-37;1-30-17-15-18-31(2)39(30)44-29-36(32-19-7-3-8-20-32)42-40(44)41(33-21-9-4-10-22-33)37-27-16-28-38(43-37)45(34-23-11-5-12-24-34)35-25-13-6-14-26-35;1-4-39(36-37-31(27-16-7-5-8-17-27)24-40(36)34-25(2)14-13-15-26(34)3)33-23-22-30-29-20-11-12-21-32(29)41(35(30)38-33)28-18-9-6-10-19-28;1-25-14-12-15-26(2)34(25)38-24-31(27-16-6-3-7-17-27)37-35(38)39-32-23-13-22-30(36-32)33(28-18-8-4-9-19-28)29-20-10-5-11-21-29;1-20-11-10-12-21(2)27(20)32-19-25(22-13-6-4-7-14-22)30-26(32)17-23-18-31(3)28(29-23)33-24-15-8-5-9-16-24;;;;;/h5-19,21-27,29-31H,3-4H2,1-2H3;3-19,21-25,27-29H,1-2H3;5-16,18,20-24H,4H2,1-3H3;3-16,18-20,22-24,33H,1-2H3;4-13,15,18-19H,17H2,1-3H3;;;;;/q5*-2;5*+2.

What are the key properties of [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+))?

[6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+)) has a molecular weight of 3665.64 g/mol, XLogP of 36.72, 37 rotatable bonds, 0 hydrogen bond donors, and 22 hydrogen bond acceptors.

Where does this data come from?

All data for [6-[1-(2,6-diethylphenyl)-4-phenylimidazol-2-yl]sulfanyl-2-pyridinyl]-diphenyl-phenylsilane;1-(2,6-dimethylphenyl)-2-[[1-methyl-2-(phenoxy)imidazol-4-yl]methyl]-4-phenylimidazole;N-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-N-ethyl-9-phenylpyrido[2,3-b]indol-2-amine;2-[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]oxy-6-[phenyl(phenyl)methyl]pyridine;6-[[1-(2,6-dimethylphenyl)-4-phenylimidazol-2-yl]-phenylboranyl]-N-phenyl-N-phenylpyridin-2-amine;pentakis(platinum(2+)) is sourced from PubChem (CID 159911586), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).